Citadel Advisors - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$5,694,555
-43.5%
462,972
-26.2%
0.00%
-50.0%
Q2 2023$10,087,413
-62.3%
627,717
-59.2%
0.00%
-60.0%
Q1 2023$26,771,444
+336.9%
1,537,705
+131.9%
0.01%
+400.0%
Q4 2022$6,127,829
-45.9%
663,185
-49.6%
0.00%
-50.0%
Q3 2022$11,327,000
+30.0%
1,315,483
+23.0%
0.00%0.0%
Q2 2022$8,716,000
-11.7%
1,069,425
+31.6%
0.00%0.0%
Q1 2022$9,870,000
-28.3%
812,363
+101.4%
0.00%0.0%
Q4 2021$13,759,000
+210.4%
403,269
+338.9%
0.00%
Q3 2021$4,432,000
-43.7%
91,877
-47.3%
0.00%
-100.0%
Q2 2021$7,872,000
-18.5%
174,265
-13.0%
0.00%0.0%
Q1 2021$9,656,000
-23.1%
200,218
-14.2%
0.00%
-50.0%
Q4 2020$12,563,000
+119.9%
233,340
+50.7%
0.00%
+100.0%
Q3 2020$5,712,000
+109.8%
154,835
+76.1%
0.00%
Q2 2020$2,723,000
-58.4%
87,900
-63.0%
0.00%
-100.0%
Q1 2020$6,551,000
+9.4%
237,301
+16.0%
0.00%0.0%
Q4 2019$5,986,000
-0.7%
204,632
-35.1%
0.00%
+50.0%
Q3 2019$6,030,000
+1.9%
315,396
+16.9%
0.00%
-33.3%
Q2 2019$5,919,000
+867.2%
269,784
+802.3%
0.00%
Q1 2019$612,000
-93.6%
29,900
-96.1%
0.00%
-100.0%
Q4 2018$9,561,000
+48.3%
758,123
+80.5%
0.01%
+66.7%
Q3 2018$6,449,000
+15.6%
420,028
-1.3%
0.00%0.0%
Q2 2018$5,578,000
+84.3%
425,480
+14.7%
0.00%
+50.0%
Q1 2018$3,027,000
+51.5%
370,894
+64.5%
0.00%
+100.0%
Q4 2017$1,998,000
-19.5%
225,454
+1.1%
0.00%
-50.0%
Q3 2017$2,481,000
-3.6%
222,920
-22.4%
0.00%0.0%
Q2 2017$2,573,000
+128.3%
287,196
+101.1%
0.00%
+100.0%
Q1 2017$1,127,000
+189.0%
142,795
+213.6%
0.00%
Q4 2016$390,000
-69.3%
45,537
-70.5%
0.00%
-100.0%
Q3 2016$1,269,000
+5.8%
154,363
+3.5%
0.00%0.0%
Q2 2016$1,199,000
+1327.4%
149,104
+1099.2%
0.00%
Q1 2016$84,000
-78.7%
12,434
-75.2%
0.00%
Q4 2015$395,000
+74.0%
50,177
+26.6%
0.00%
Q3 2015$227,000
+70.7%
39,630
+61.8%
0.00%
Q2 2015$133,000
-87.0%
24,500
-88.8%
0.00%
-100.0%
Q1 2015$1,023,000
+8.9%
219,156
-2.7%
0.00%0.0%
Q4 2014$939,000
+18.0%
225,125
+47.3%
0.00%0.0%
Q3 2014$796,000
+6.8%
152,842
-31.9%
0.00%0.0%
Q2 2014$745,000
+69.7%
224,291
+77.2%
0.00%0.0%
Q1 2014$439,000
+41.6%
126,591
+47.6%
0.00%
Q4 2013$310,000
+297.4%
85,771
+231.7%
0.00%
Q3 2013$78,00025,8550.00%
Other shareholders
NEOGENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders